• Home >>
  • Pharmaceuticals and Healthcare >>
  • Legal Medical Cannabis Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Legal Medical Cannabis Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240314 21st May, 2018 Region : Global Pages Reports Monitor

Global Legal Medical cannabis Market Research Report - by Application (Chronic Pain, Arthritis, Migraine, Cancer and Other), and forecast till 2025


Market Scenario:-

Medical cannabis is a pain management drug extracted from cannabis plant. Medical cannabis is primarily prescribed as analgesic in indications like vomiting, nausea and muscle pain. The cannabis consists of cannabinoids compounds such as cannabidiol and tetrahydrocannabinol. while, other compounds are also found in the cannabis in less proportion includes health benefits and medical properties like cannabinol and cannabigerol. THC compound frequently gets users high owing to its advanced concentration in the cannabis. The cannabinoids cooperates with the body’s endocannabinoid system that works as a signalling network in the mammalian or human species.

Emergence of luxury cannabis products is emerging nowadays. several vendors selling luxury cannabis products that makes controlled consumption of cannabis beneficial to the users have emerged in the market as the consumption of cannabis through smoking can be harmful. The mounting number of countries and states are getting approval for using it in therapeutic applications is one of the decisive factors driving the market. Cannabis has short term as well as long term side effects including hallucination, changing mood and anxiety, sleepiness, and paranoia. The regular inhalation of cannabis can make breathing problems such as bronchitis that might hinder the demand of cannabis in medical treatment and restrain the growth of the global medical cannabis market. The erratic and stringent rules and regulations from region to region for the use of cannabis as a medical treatment, may also slow down the growth of the global medical cannabis market.

Market segmentation:-  

Global legal medical cannabis market is segmented on the basis of applications and regions. Based on region, the market is divided into cancer, chronic pain, arthritis, migraine, and others. Increasing chronic pain disorders is anticipated to boost the growth of the market during the forecast period. Based on region, the global legal medical cannabis market is segmented covering North America, Europe, Asia-Pacific, and LAMEA.

Regional analysis:-

Based on region, the global medical cannabis market can be divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to grow the global medical cannabis market in terms of revenue. Legalization of cannabis for recreational and medicinal  use in the region and agreement of the drugs for therapeutic application are fostering the growth of the market in North America. Asia Pacific is also predicted to grow at a hasty pace during the forecast period. Growth of the market in the region is attributed to increasing authorization of medical cannabis as well as towering R&D investment in cancer research.

Key players:- 

• ABcann Medicinals Inc.

• Agripharm Corp.

• Aurora Cannabis Enterprises Inc.

• Broken Coast Cannabis Ltd.

• Emerald Health Botanicals Inc.

• Tweed Inc.

• Medical Marijuana Inc.

• Abattis Bioceuticals Corp.

• Cresco Labs, LLC

• Whistler Medical Marijuana Corp.

Legal medical cannabis market segmentation: -

By Application :-

• Chronic Pain

• Arthritis

• Migraine

• Cancer

• Others

By Geography:-

Medical Marijuana Market:

By Application:-

• Chronic Pain

• Arthritis

• Migraine

• Cancer

• Others


By Geography:-

• North America

o U.S.

o Canada

o Mexico


• Europe

o Belgium

o Netherland

o Italy

o Switzerland

o Czech Republic

o Finland

o Rest of Europe


• Asia-Pacific

o Australia

o Chile

o Rest of Asia Pacific


• LAMEA

o Israel

o Rest of LAMEA

The study for Global Legal Medical Cannabis Market will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2015  Base Year Estimate: 2016  Forecast: 2018 to 2025

The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market.  
 
1. Introduction
1.1. Market Definition
1.2. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions

3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 

4. Application Overview
4.1. Introduction
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Chronic Pain
4.2.2. Arthritis
4.2.3. Migraine
4.2.4. Cancer
4.2.5. Others
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

5. Regional Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. North America
5.2.1.1. U.S.
5.2.1.2. Canada
5.2.1.3. Mexico 
5.2.2. Europe
5.2.2.1. UK
5.2.2.2. Germany
5.2.2.3. France
5.2.2.4. Italy 
5.2.2.5. Spain
5.2.2.6. Rest of Europe
5.2.3. Asia-Pacific
5.2.3.1. China
5.2.3.2. India
5.2.3.3. Japan
5.2.3.4. South Korea
5.2.3.5. Rest of Asia-Pacific
5.2.4. LAMEA
5.2.4.1. Brazil
5.2.4.2. UAE
5.2.4.3. South Africa
5.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

6. Manufacturer/ Vendor Profile
6.1. The following attributes will be considered while profiling key manufacturers in this industry: 
6.1.1. Company Overview
6.1.2. Financial Synopsis
6.1.3. Recent Developments
6.1.4. R&D Investments (if any)
6.1.5. Strategy Overview (Analyst Perspective)
6.1.6. Product Portfolio
6.2. Companies Profiled
6.2.1. ABcann Medicinals Inc.
6.2.2. Agripharm Corp.
6.2.3. Aurora Cannabis Enterprises Inc.
6.2.4. Broken Coast Cannabis Ltd.
6.2.5. Emerald Health Botanicals Inc.
6.2.6. Tweed Inc.
6.2.7. Medical Marijuana Inc.
6.2.8. Abattis Bioceuticals Corp.
6.2.9. Cresco Labs, LLC
6.2.10. Whistler Medical Marijuana Corp.
(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]